A Review  on Relationship Between Human Endogenous Retrovirus Groups and Human Diseases by Aramideh khouy, reza et al.
  Archives of Medical Laboratory Sciences  
 
 Archives of Medical Laboratory Sciences 
1 
Review Article  
 
 
A Review  on Relationship Between Human Endogenous 
Retrovirus Groups and Human Diseases 
 
Reza Aramideh khouy1, Mehrnaz Hosseini Tehrani1, Hamed Nosrati2,  Maryam Esghaei1* 
 
 1 Department of Virology, Iran University of Medical Sciences, Tehran, Iran  
2 Department of Tissue Engineering, Faculty of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran 
 
Received: 23 June, 2018, Accepted: 24 November , 2018 
Abstract 
Various factors are involved in the incidence of some diseases like autoimmune, psychiatric and cancerous ones. One 
of these probable factors is considered as the endogenous retroviruses, for example, proviruses that have been 
introduced in previous generations in some organisms' genome, and make up over 8% of the human genome. Recent 
studies have indicated that these factors and their related products (including RNA, cytosolic DNA, and proteins) 
may affect and also change the host cell function and immune system. This review summarizes the detailed 
information about the structure, classification, and pathogenesis mechanism of human endogenous retroviruses and 
their relationship with the autoimmune diseases and some kinds of cancers. 
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About 45% of the human genome contains the 
intergenic regions. The genome of all studied 
eukaryotes (from yeast to humans) has these intergenic 
regions variety and it has aspects of hereditary into the 
next generation. Retrotransposons are an important 
part of these areas, which were divided into elements 
containing long terminal repeat (LTR) and LTR-free. 
The most common retrotransposons are endogenous 
retroviruses (ERVs) containing LTR in humans, and 
can express viral proteins similar to the exogenous 
retroviruses (1, 2). HERV products in most cases can 
increase antigenic sensitivity and reciprocal reactivity 
against host antigens. Current studies use retroviruses 
as an indication of autoimmune disease and cancer 
pathology (3). Here, we reviewed endogenous 
retroviruses and discussed about  their classification, 
pathogenesis and  possible association of various 
human endogenous retrovirus (HERV) groups with 
autoimmune diseases, nervous system diseases and 
cancer. Identification of  endogenous viruses 
association  with various diseases not only helps to 
diagnose the pathology, but also provides an 
appropriate therapeutically approach for related 
disorders. 
 
Human endogenous retrovirus (HERV) 
Endogenous viruses have been derived from 
their exogenous counterparts, due to the germline 
infection and their proliferation amongst their host 
genomes (4). These viruses are a big part of a larger 
family of retroviral elements, which is composed of  
about 5-8% of the human genome (5). The HERVs 
structure includes gag, pol and env that are surrounded 
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by LTR regions on both sides, as same as exogenous 
retroviruses. Briefly, gag encodes the matrix, the 
capsid and the nucleocapsid proteins, and pol encodes 
protease (PR), reverse transcriptase (RT), 
Ribonuclease H (RNase H)  ,integrase (IN), and env 
encodes virus coat proteins. HERVs also contains the 
primer binding site (PBS) sequence, between 5'LTR 
and gag, and polypurine tract (PPT), between 3'LTR 
and env. Specifically,  the first is the binding site of the 
tRNA primer for the negative strand synthesis, and the 
second one is the binding site of the primer for  the 
positive strand synthesis (6-8). Moreover, the HERV-
K group (HML2) encodes two accessory proteins 
named Np9 and Rec, which are derived from 
alternative splicing of the env transcript. The 
expression of  these two proteins has been 
demonstrated in cancerous cells (9). The LTR 
sequence that contains U3-R-U5 plays an important 
role in the regulating viral gene expression. These 
regions, which can act as alternate promoters and 
enhancers, often contribute to the transcriptomes 
production  in different cells(6, 8). 
 
Classification of HERVs 
Because of the lack of appropriate 
nomenclature,  HERVs classification has been 
remained uncompleted (8). Based on their homology 
with animal retroviruses, HERVs are categorized into 
three main classes: class I is similar to the 
Gammaretrovirus and Epsilonretrovirus; class II is 
similar to Betaretrovirus and finally class III is similar 
to the Spumaretrovirus. Individual nomenclature of 
HERVs is accomplished based on various 
characteristics in which there is no specific pattern. for 
example, some HERVs were named based on the 
amino acids along with tRNA-Primer, which were 
bonded to PBS (like HERV-E for glutamic acid and 
HERV-W for tryptophan). Some others were named 
based on their proximity to a specific gene (like 
HERV-ADP) or a specific motif (like HERV-FRD). In 
terms of the common structural features of HERVs, 
they have been categorized into 39 “canonical” groups 
and 31 “noncanonical” clades using the Retro Tector 
software (10-15)(Table1). 
Pathogenicity mechanism  
HERVs and their products (including RNA, 
cytosolic DNA and proteins) could affect and alter the 
host's immune system, for example it is recommended 
that these factors may play an important role in the 
immune system's evolution and its function(16). They 
affect the host with different ways: 
 Integration of the DNA of provirus into the 
genome: HERVs integration at any location 
on the host genome could affect their adjacent 
genes activity even if they were not translated 
or replicated. Also, LTRs can have an 
inhibitory or activating effect on the promoter 
/ gene enhancer in proximity to the HERV 
integration region (17).  HERVs integration in 
the introns, can modify the starting and ending 
of the transcription region, and would lead to 
an mRNA with abnormal activities. They can 
also create different splicing locations, which 
ultimately affect  the produced mRNA 
functions in negative way(18).  
 HERVs effect on the innate immune system: 
These agents may play an important role in 
forming and expanding of the interferon 
signaling network and the host innate immune 
system. Consequently, their replication leads 
to inflammatory and autoimmune disorders 
and control the immune system over-
activation throughout inhibitory properties  
(16, 19-21).  
Table1. Classification of HERVs (adapted from Vargiu et al., 2016) 
Class Type species Clade 
Class I (gamma-like, epsilon-like) 
Murine leukemia virus (MLV) 
Feline leukemia virus (FeLV) 
Walleye dermal sarcoma virus (WDSV) 
Canonical 27 Noncanonical 
25 
Class II (beta-like) 
Mouse mammary tumor virus (MMTV) 
Mason-Pfizer monkey virus (MPMV) 
Jaagsiekte sheep retrovirus (JSRV) 
Canonical 10 
 
Class III (spuma-like) 
 
Simian foamy virus (SFV) Canonical 2 Noncanonical 5 
Uncertain_Errantilike Gypsy retrovirus Noncanonical 1 
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 The HERV proteins effect on the immune 
system: Evidences from HERV protein 
expression indicated that these products affect  
their hosts immune system. The analogy of 
these proteins with antigenic epitopes and 
their identification by immune cells causes 
some responses by the host’s immune system 
and that can lead to higher pathogens 
tolerance in the host immune system in the 
long run. 
In one animal model study,  it was shown that  
those encoded antigen by ERV can be detected by T 
cells, and an immune response can be created for 
counteraction (22). Another study showed that HERV-
K18 env stimulates the Vβ7-expressing T-cells in 
humans and transgenic mice (21, 23). Other products 
including env in HERV-E and HERV-H or Syncytin in 
HERV-W can be identified by the host immune system 
and moreover they can  stimulate the immune system.  
(21).  
 
HERV in autoimmune diseases and 
psychiatric disorders 
Studies have suggested the direct and indirect 
relationship between the HERVs and various kinds of 
diseases. For example, HERV-H/F and HERV-
W/MSRV have been demonstrated to be activated in 
patients with multiple sclerosis (MS). In addition, the 
level of HERV RNA and associated antigens increase 
in the mononuclear brain and peripheral blood cells 
(PBMCs) (24, 25). 
Due to uncertainty about the pathology of 
schizophrenia, different speculations have been 
deduced,  however, the HERV-W and HERV-K 
presence in clinical samples of these patients can be 
considered as important keys for understanding of the 
disease pathology (26, 27). An increase in the HERV-
related products such as reverse transcriptase has been 
observed in the patients with amyotrophic lateral 
sclerosis (ALS) (28).  
The relationship between endogenous 
retroviral agents with other autoimmune diseases like 
RA, SLE, T1D, EAE, etc. has been also investigated, 
and indicated the role of these agents in immune-
related diseases and psychiatric disorders (29-31) 
(Table 2).  
HERVs and cancer  
Cancer refers to a set of diseases resulting 
from the uncontrolled cell proliferation. Genetic and 
environmental risk factors are considered as the most 
important factors in the cancers incidence. Studies 
have shown a correlation between HERVs and many 
types of tumors like melanoma, breast cancer, germ 
cell tumors, liver cancer and also ovarian cancer (32, 
33). The unusual  HERVs expression in some of the 
body cells, like the HERV-K elements in the germ cell 
tumor and melanoma indicates the association between 
these factors with cancer cells (34). Some 
investigations have indicated a significant increase in 
antibody titer against the provirus in patients with 
ovarian cancer (35). The HERV-K-related proteins 
expression has been also observed in patients with 
breast cancer (36). Studies have indicated the 
association between different HERV groups with 
different cancer types (Table3).  
Conclusion  
This study provides a review of the relation between 
different human endogenous viruses and the 
autoimmune, neurological and cancerous disorders. 
The endogenous proviruses presence amongst human 
genes and their compliance with Mendelian inheritance 
laws have raised questions, which researchers have 
been seeking for answering to it over the past few 
years. Existence of many questions and few answers 
indicated our little knowledge about this provirus's 
role. The definite relationship between these 
proviruses and MS is established by accomplishing 
some clinical studies on MS patients. However, the 
mechanism of this relationship is still unclear. Other 
researches in this field also recommend that numbers 
of autoimmune and psychiatric diseases and cancers 
are associated with endogenous proviruses. The 
presence of these factors and the possibility of 
interference in  the immune and cellular systems 
normal process would result in  the best and worst fate 
for the cells and cellular factors. The  former one led 
us to have a  deeper view into the usage of antiviral 
drugs in the endogenous retrovirus-related diseases 
treatment. However, the latter one led to use  these 
factors in the treatment and control of further diseases. 
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Table2. List of endogenous retrovirus groups related with diseases 
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MS, Multiple Sclerosis; RA, Rheumatoid arthritis; T1DM, Type 1 diabetes mellitus; 
SLE, Systemic lupus erythematosus; CIDP, Chronic Inflammatory Demyelinating 
Polyneuropathy; EAE, Experimental autoimmune encephalomyelitis; SS, Sjögren's 
syndrome; PBL, peripheral blood lymphocytes 
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